PFKM and cardiac hypertrophy: As PFK2 is a central regulator of glycolysis through allosteric control of the enzyme PFK1, the authors showed that low PFK1 activity through expression of a kinase-dead PFK2 transgene (GlycoLo hearts) recapitulated physiologic cardiac hypertrophy — including a similar gene expression profile (101).